Abzena consolidating UK and West Coast US operations
Abzena Plc has begun consolidating its UK operations at a facility in Cambridge and leased a plant in San Diego, US to consolidate its West Coast production activities.
Abzena Plc has begun consolidating its UK operations at a facility in Cambridge and leased a plant in San Diego, US to consolidate its West Coast production activities.
News in brief
Recent acquisitions CMC Biologics and Biomeva have been brought together under the single AGC Biologics brand in efforts to consolidate its CDMO business.
Takeda has said it will review the manufacturing of Alofisel (darvadstrocel) if its €520m ($620m) bid for off-the-shelf stem cell developer TiGenix is successful.
Novo Nordisk has called on the board of directors at Ablynx to engage in negotiations after the antibody-fragment tech firm rejected its €2.6bn ($3.1bn) acquisition offer.